Feasibility of the LUM Imaging System for Detection of Prostate Cancer
Latest Information Update: 28 Feb 2022
At a glance
- Drugs Pegulicianine acetate (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- Sponsors Lumicell
Most Recent Events
- 08 Feb 2022 Status changed from active, no longer recruiting to discontinued (reason: Interim analysis indicated a change in study design to collect in vivo data)
- 10 Sep 2021 Planned End Date changed from 1 Sep 2021 to 1 Dec 2021.
- 30 Jun 2020 Planned End Date changed from 1 Dec 2019 to 1 Sep 2021.